| Website | tarisbiomedical.com |
| Category | BioTech |
| Phone | 781-676-7750 |
| info@TARISbio.com | |
| Employees | |
| Founded | 2008 |
| Description | Pharmaceutical Company |
| TOTAL | $46.8M |
| FUNDING TOTAL | $46.8M |
| Series A, 6/09 Flagship Ventures Flybridge Capital Partners Polaris Partners | $15M |
| Series B, 4/11 Third Rock Ventures Flagship Ventures Flybridge Capital Partners Polaris Partners | $18.3M |
| Private Equity, 3/13 Flagship Ventures Flybridge Capital Partners Polaris Partners Third Rock Ventures | $13.5M |
TARIS Biomedical a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatments have failed.